Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.900
+0.020 (1.06%)
At close: Apr 28, 2026, 4:00 PM EDT
1.890
-0.010 (-0.53%)
Pre-market: Apr 29, 2026, 6:01 AM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $73.61 million as of April 29, 2026. Its market cap has increased by 44.94% in one year.
Market Cap
73.61M
Enterprise Value
-42.26M
1-Year Change
44.94%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $73.61M, a decrease of -68.69%. That is a compound annual growth rate of -28.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 73.61M | -3.20% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 78.00M |
| aTyr Pharma | 77.81M |
| XBiotech | 77.44M |
| MAIA Biotechnology | 75.84M |
| ImmuCell | 75.81M |
| PMV Pharmaceuticals | 75.73M |
| TScan Therapeutics | 75.73M |
| Filana Therapeutics | 75.36M |